SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients

NCT07143773 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplantation Recipients
Sodium-Glucose Transporter 2 Inhibitors
Non-Diabetic Patients
Randomized Controlled Trial
Placebo Control Design

Interventions

DRUG: SGLT-2 inhibitor
DRUG: Placebo

Sponsor

Odense University Hospital

Collaborators

[object Object]
[object Object]
[object Object]